JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
CALL
WisdomTree US Total Dividend Fund
DTD
$1.69B
| $18.6M | ﹤0.01% |
1,390,000
-1,000
| -0.1% | -$50.9K |
|
1602
CALL
Sarepta Therapeutics
SRPT
$1.89B
| $18.6M | ﹤0.01% |
144,100
+69,400
| +93% | +$7M |
|
|
UFS
1603
DELISTED
DOMTAR CORPORATION (New)
UFS
| $18.6M | ﹤0.01% |
485,299
-79,892
| -14% | -$2.96M |
|
|
GOOD
1604
Gladstone Commercial Corp
GOOD
$623M
| $18.5M | ﹤0.01% |
848,041
+358,672
| +73% | +$8.14M |
|
1605
Devon Energy
DVN
$49.7B
| $18.5M | ﹤0.01% |
713,787
-74,925
| -9% | -$1.69M |
|
1606
Myriad Genetics
MYGN
$301M
| $18.5M | ﹤0.01% |
678,373
+180,752
| +36% | +$4.97M |
|
1607
ING
ING
$102B
| $18.4M | ﹤0.01% |
1,530,410
-300,663
| -16% | -$3.44M |
|
1608
iShares MSCI Taiwan ETF
EWT
$11.4B
| $18.4M | ﹤0.01% |
448,313
-1,791,449
| -80% | -$70.6M |
|
|
EBSB
1609
DELISTED
Meridian Bancorp, Inc.
EBSB
| $18.4M | ﹤0.01% |
917,436
-70,844
| -7% | -$1.39M |
|
1610
Alcoa
AA
$14B
| $18.4M | ﹤0.01% |
856,249
+293,871
| +52% | +$6.08M |
|
1611
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.78B
| $18.4M | ﹤0.01% |
602,566
-22,292
| -4% | -$680K |
|
1612
Harley-Davidson
HOG
$2.71B
| $18.4M | ﹤0.01% |
494,338
-360,584
| -42% | -$13.4M |
|
1613
Pentair
PNR
$10.6B
| $18.3M | ﹤0.01% |
399,207
-280,289
| -41% | -$11.8M |
|
1614
Independent Bank
INDB
$4.02B
| $18.3M | ﹤0.01% |
219,611
+169,742
| +340% | +$13.9M |
|
1615
American Financial Group
AFG
$12B
| $18.3M | ﹤0.01% |
166,487
-37,963
| -19% | -$4.06M |
|
1616
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
$9.43B
| $18.2M | ﹤0.01% |
539,595
-34,703
| -6% | -$1.15M |
|
1617
Deluxe
DLX
$1.09B
| $18.2M | ﹤0.01% |
363,974
-17,515
| -5% | -$872K |
|
1618
Customers Bancorp
CUBI
$2.79B
| $18.2M | ﹤0.01% |
763,020
-231,107
| -23% | -$5.31M |
|
1619
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.51B
| $18.2M | ﹤0.01% |
469,437
+176,881
| +60% | +$6.84M |
|
1620
Adient
ADNT
$1.45B
| $18.1M | ﹤0.01% |
850,825
+240,833
| +39% | +$5.34M |
|
|
CNXM
1621
DELISTED
CNX Midstream Partners LP
CNXM
| $18.1M | ﹤0.01% |
1,097,735
-453,659
| -29% | -$6.52M |
|
1622
Commercial Metals
CMC
$7.91B
| $18.1M | ﹤0.01% |
810,849
-355,223
| -30% | -$7.19M |
|
|
MTOR
1623
DELISTED
MERITOR, Inc.
MTOR
| $18M | ﹤0.01% |
689,172
-839,390
| -55% | -$18.9M |
|
1624
Methode Electronics
MEI
$604M
| $18M | ﹤0.01% |
458,352
-85,358
| -16% | -$3.1M |
|
|
MASI
1625
DELISTED
Masimo
MASI
| $18M | ﹤0.01% |
113,834
+201
| +0.2% | +$30.2K |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.